Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1051 - 1075 of 1457 in total
SU-11652 is a tyrosine kinase inhibitor.
Experimental
Encenicline has been investigated for the treatment of Cognition, Schizophrenia, Alzheimer's Disease, Cardiac Repolarization, and Central Nervous System Diseases.
Investigational
CE-224535 has been used in trials studying the treatment of Osteoarthritis.
Investigational
Pyronaridine has been investigated for the treatment of Malaria.
Investigational
Halofuginone is a low molecular weight quinazolinone alkaloid, and a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also effectively suppresses tumor progression and metastasis in mice. Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and received orphan drug designation from the U.S....
Investigational
Vet approved
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.
Experimental
Investigational
Arbaclofen Placerbil is a prodrug of Arbaclofen, which is a selective gamma-amino-butyric acid type B receptor agonist and the R-enantiomer of baclofen. It was discovered, and has been patented by XenoPort as a new chemical entity with an improved pharmacokinetic profile compared to baclofen, which allows for sustained release properties....
Investigational
Florfenicol is a fluorinated synthetic analog of thiamphenicol.
Experimental
Vet approved
Letaxaban has been used in trials studying the treatment and prevention of Venous Thromboembolism and Acute Coronary Syndrome.
Investigational
CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Experimental
Displaying drugs 1051 - 1075 of 1457 in total